Evaluation of the effect of preoperative rectal misoprostol use on the postoperative outcomes of hysteroscopic myomectomy
Journal of Obstetrics and Gynaecology Research · 2023
DOI: 10.1111/jog.15681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2023. Verfasst von Cenk Mustafa Güven und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Izmir Private Can Hospital, Izmir, Turkey. Hauptthemen laut MEDLINE: Uterine Myomectomy, Misoprostol, Leiomyoma, Uterine Neoplasms. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Aim
In this study, we aimed to evaluate the effect of using two doses of rectal misoprostol on postoperative results in hysteroscopic myomectomy.
Methods
This retrospective study was carried out at two hospitals in which the medical records of patients who underwent hysteroscopic myomectomy between November 2017 and April 2022 were evaluated, and subjects were grouped depending on the administration of misoprostol before hysteroscopy. In recipients, two rectal doses of misoprostol (400 μg) were administered, 12 h and 1 h before the planned operation. Outcomes evaluated were: postoperative reduction in hemoglobin (Hb), pain at 12 and 24 h (VAS score), and length of hospital stay.
Results
The mean age of 47 women in the study group was 27.38 ± 5.12 (range 20–38) years. Hb levels reduced significantly in both groups after hysteroscopic myomectomy ( p < 0.001). In misoprostol recipients, VAS score was found to be significantly lower at 12 h ( p < 0.001) and 24 h after the operation ( p = 0.004). Multiple linear regression analyses for each of the outcomes revealed the following: greater myoma size was associated with greater Hb decrease ( p = 0.010), misoprostol use was associated with lower 12th and 24th hour VAS scores ( p < 0.001), longer duration of operation was associated with higher 12th and 24th hour VAS scores ( p < 0.001), and finally, longer duration of operation was associated with prolonged hospital stay ( p = 0.001).
Conclusions
The use of two doses of rectal misoprostol before hysteroscopic myomectomy was effective in reducing postoperative pain. Prospective, population‐based studies evaluating different uses of misoprostol in hysteroscopic myomectomy are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Izmir Private Can Hospital, Izmir, Turkey.
- Department of Obstetrics and Gynecology, Private Erciyes-Kartal Hospital, Kayseri, Turkey.
ORCID-Profile: Cenk Mustafa Güven, Zerrin Avul
Zitieren
APA
Güven, C. M., & Avul, Z. (2023). Evaluation of the effect of preoperative rectal misoprostol use on the postoperative outcomes of hysteroscopic myomectomy. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.15681
Vancouver
Güven CM, Avul Z. Evaluation of the effect of preoperative rectal misoprostol use on the postoperative outcomes of hysteroscopic myomectomy. Journal of Obstetrics and Gynaecology Research. 2023. doi:10.1111/jog.15681
BibTeX
@article{Gven2023,
author = {Güven, Cenk Mustafa and Avul, Zerrin},
title = {Evaluation of the effect of preoperative rectal misoprostol use on the postoperative outcomes of hysteroscopic myomectomy},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2023},
doi = {10.1111/jog.15681}
}
EUVIMED